an overview of the pathophysiology of pnh
Published 2 years ago • 327 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
1:43
the changing treatment landscape of pnh: novel agents and combinations
-
1:39
new horizons in pnh
-
1:41
a look at the future treatment landscape of pnh
-
4:22
pnh: when blood machinery goes wrong
-
1:12
future advancements in the treatment of pnh
-
50:34
the pnh patient's journey: a snapshot of short and long term effects 6/14/17
-
3:30
paroxysmal nocturnal hemoglobinuria
-
1:27:06
pnh 101: what you need to know (2018)
-
1:41
thrombosis: a lethal complication in pnh
-
11:54
paroxysmal nocturnal hemoglobinuria (pnh) | hemolytic anemia | complement alternative pathway
-
0:45
non-pharmaceutical interventions for patients with mpns and other hematological malignancies
-
1:29
treating patients with pnh and aa
-
1:25
the current approach to managing patients with prefibrotic pmf
-
2:21
the potential applications for immunotherapy in mpns
-
1:34
are thrombotic risk and progression in et predictable?
-
1:20
the impact of early ruxolitinib treatment on os in the comfort-i and comfort-ii studies
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
1:12
contemporary challenges in polycythemia vera management
-
2:26
an insight into the aims of the eurasian hematology-oncology group
-
0:52
insights from advance iv study: efgartigimod increases platelet counts of patients with itp
-
2:20
overview of paroxysmal nocturnal hemoglobinuria (pnh)
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp